Related references
Note: Only part of the references are listed.The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer
Natalia Partain et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: A trial of the ECOG-ACRIN Research Group (E2108)
Fengmin Zhao et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01
Atilla Soran et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Factors associated with improved outcomes for metastatic inflammatory breast cancer patients
Anna Weiss et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Survival of patients with metastatic breast cancer with or without locoregional therapy Reply
Rajendra Badwe et al.
LANCET ONCOLOGY (2015)
Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer
Catherine L. Akay et al.
CANCER (2014)
Share Paper
